Seizure outcome in patients with cavernous malformation after early surgery

Epilepsy Behav. 2021 Feb:115:107662. doi: 10.1016/j.yebeh.2020.107662. Epub 2020 Dec 15.

Abstract

Objective: To describe seizure outcome and complications in patients with cavernous malformations (CM) undergoing early versus late surgery.

Methods: A database was created for all CM patients who presented with seizure referred to the neurosurgical clinic at an academic center. A telephone survey and chart review were conducted to evaluate for preoperative and postoperative seizure frequency. Postoperative seizure-free outcome of patients who had ≤2 preoperative seizures versus those that had >2 preoperative seizures was compared.

Results: A total of 35 CM patients were included for analysis. Nineteen patients had ≤2 preoperative seizures and 16 patients had >2 preoperative seizures, six of them drug resistant for over two years. Among the ≤2 seizure group, 15 had only a single seizure before surgical resection. 94.7% of patients with ≤2 preoperative seizures and 62.5% of patients with >2 preoperative seizures were seizure free one year following surgical resection (p = 0.019). 78.9% of patients with ≤2 preoperative seizures and 25% of patients with >2 preoperative seizures were able to wean off AEDs (p < 0.001). Among those patients who had a single preoperative seizure, 100% of patients were seizure free at one year.

Conclusions: Early surgical resection for CM patients who present after a CM-related seizure is an effective, well tolerated treatment and has good chance to offer seizure freedom without the need for long-term antiepileptic medications. Outcome for patients operated with only one or two preoperative seizures may lead to better results than patients who delay the procedure.

Keywords: Cavernoma; Cavernous malformation; Epilepsy surgery; First seizure; Intractable epilepsy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticonvulsants / therapeutic use
  • Hemangioma, Cavernous, Central Nervous System* / complications
  • Hemangioma, Cavernous, Central Nervous System* / surgery
  • Humans
  • Retrospective Studies
  • Seizures / drug therapy
  • Treatment Outcome

Substances

  • Anticonvulsants